These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3164355)

  • 1. [Tissue distribution of CA-125 in female reproductive organs].
    Matsubara J; Mizunuma H; Nagumo H; Ibuki Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):568-74. PubMed ID: 3164355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanism of the increase in the serum CA125 concentration in patients with endometriosis].
    Kobayashi H; Miyake W; Yamashita M; Kanayama N; Hayata T; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):467-72. PubMed ID: 3163715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CA 125 levels in patients with endometriosis: changes in CA 125 levels during menstruation.
    Masahashi T; Matsuzawa K; Ohsawa M; Narita O; Asai T; Ishihara M
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):328-31. PubMed ID: 3165507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA 125 in serum, peritoneal fluid, active lesions, and endometrium of patients with endometriosis.
    Fedele L; Vercellini P; Arcaini L; da Dalt MG; Candiani GB
    Am J Obstet Gynecol; 1988 Jan; 158(1):166-70. PubMed ID: 3422132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycle variation and distribution in the concentration of cytosol estrogen and progesterone receptors in the normal human uterus and myoma.
    Ochiai K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):945-52. PubMed ID: 7240872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary application of carbohydrate antigen CA-50 radioimmunoinhibition test in diagnosing and monitoring cancers].
    Chen ZZ; Fan ZF; Su P
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):436-8. PubMed ID: 2838242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
    Iwasaka T; Ohkuma Y; Yoshimura T; Sugimori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA-125 levels in endometriosis.
    Patton PE; Field CS; Harms RW; Coulam CB
    Fertil Steril; 1986 Jun; 45(6):770-3. PubMed ID: 2423378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CA 125 measurements in the diagnosis of endometriosis recurrence.
    Fedele L; Arcaini L; Vercellini P; Bianchi S; Candiani GB
    Obstet Gynecol; 1988 Jul; 72(1):19-22. PubMed ID: 2967943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential diagnosis between leiomyomata uteri and adenomyosis using CA 125 as a new tumor marker of ovarian carcinoma].
    Takahashi K; Kijima S; Yoshino K; Shibukawa T; Moriyama M; Iwanari O; Sawada K; Matsunaga I; Murao F; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):591-5. PubMed ID: 3857281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-soluble antioxidants: beta-carotene and alpha-tocopherol levels in breast and gynecologic cancers.
    Palan PR; Goldberg GL; Basu J; Runowicz CD; Romney SL
    Gynecol Oncol; 1994 Oct; 55(1):72-7. PubMed ID: 7959271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospects of the use of neoplasm antigens as markers of gynecologic diseases].
    Adamian LV; Fanchenko ND; Andreeva EN; Novikov EA; Alekseeva ML
    Sov Med; 1990; (6):26-9. PubMed ID: 2204116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients.
    Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
    Cancer Res; 1988 Mar; 48(6):1435-8. PubMed ID: 3162196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
    Kivinen S; Kuoppala T; Leppilampi M; Vuori J; Kauppila A
    Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor markers in gynecologic diseases].
    Geyer H; Kleine W
    Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):168-72. PubMed ID: 3472991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle.
    Zeimet AG; Müller-Holzner E; Marth C; Daxenbichler G; Dapunt O
    Fertil Steril; 1993 May; 59(5):1028-35. PubMed ID: 8486169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.